Andrew Lo - 12 Jun 2025 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Reporting relationship: Director
Issuer ticker: ABCL
Reported as of: 12 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2025, 17:30:33 UTC
Prior SEC filing: 06 May 2025
Next SEC filing: 24 Jun 2025
Source filing: View source filing
Reporting owner signature: Tryn Stimart, attorney-in-fact

Key filing fact

Andrew Lo filed Form 4 for AbCellera Biologics Inc. (ABCL) on 16 Jun 2025.

Key facts

This page summarizes Andrew Lo's Form 4 filing for AbCellera Biologics Inc. (ABCL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 16 Jun 2025, 17:30.

Change

Previous filing in this sequence was filed on 06 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001679076 Primary reporting owner

Lo Andrew

Relationship: Director
Address: C/O ABCELLERA BIOLOGICS INC, 150 W 4TH AVENUE, VANCOUVER, BRITISH COLUMBIA, CANADA
Signature: Tryn Stimart, attorney-in-fact
Signature date: 16 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ABCL transaction Derivative

Share option (right to buy)

Award

Transaction value: $0
Shares: +238,864
Change %: +79%
Price: $0.000000
Shares after: 541,354
Date: 12 Jun 2025
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 238,864
Exercise price: $3.15
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to such option vest and become exercisable at the 2026 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date.